---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-100787"
form_type: "8-K"
ticker: "RZLT"
cik: "0001509261"
company_name: "Rezolute, Inc."
filed_at: "2023-09-14T23:59:59+00:00"
generated_at: "2026-06-10T17:33:04.821375+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Rezolute reports FY2023 net loss of $51.8M; Phase 3 for RZ358 to start Q4 2023

## Summary
- Cash and equivalents $16.0M, marketable securities $102.3M as of June 30, 2023.
- Full year net loss $51.8M vs $41.1M prior year; R&D spend $43.8M (up from $32.5M).
- Phase 3 sunRIZE study for RZ358 in congenital HI to initiate Q4 2023; topline data H1 2025.
- Phase 2 study of RZ402 for diabetic macular edema ongoing; results expected Q1 2024.
- Q4 net loss $12.7M vs $9.4M in prior year quarter.

## SEC filing metadata
- accession: 0001104659-23-100787
- form_type: 8-K
- ticker: RZLT
- cik: 0001509261
- company_name: Rezolute, Inc.
- filed_at: 2023-09-14T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1509261/000110465923100787/0001104659-23-100787-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1509261/000110465923100787/tm2325841d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-100787
- JSON: https://secwatch.observer/filing/0001104659-23-100787.json
- Plain text: https://secwatch.observer/filing/0001104659-23-100787.txt

## Key facts
- Earnings Releases
  Rezolute, Inc. reported financial results for the fourth quarter and full fiscal year ended June 30, 2023.
  - Period: the fourth quarter and full fiscal year ended June 30, 2023
  - Result: reported results
  source text: On September 14, 2023, Rezolute, Inc. issued a press release announcing its financial results for the fourth quarter and fiscal year ended June 30, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1509261/000110465923100787/0001104659-23-100787-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.